The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. (Q35169751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Hugh D C Smyth

series ordinal

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

807-828

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

Stratospheric sink for chlorofluoromethanes: chlorine atom-catalysed destruction of ozone

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Large losses of total ozone in Antarctica reveal seasonal ClO x /NO x interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Drug-surfactant-propellant interactions in HFA-formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Estimation of pulmonary deposition of aerosol using gamma scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

MDIs: physics of aerosol formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

CFC transition: the emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Targeting drugs to the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Why particle size should affect clinical response to inhaled therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

1 reference

7 January 2021

Inhalation therapy of the future--how will it change the way we treat asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Reduction in patient timing errors using a breath-activated metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Influence of Formulation on Aerosol Particle Size

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Modulation of aerosol clouds produced by pressurised inhalation aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Transition to CFC-free metered dose inhalers--into the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Hollow porous particles in metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Dosing reproducibility from experimental albuterol suspension metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Non-CFC metered dose inhalers: the patent landscape

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Application of co-grinding to formulate a model pMDI suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Innovations and perspectives of metered dose inhalers in pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Determination of drug solubility in aerosol propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Solution and adsorption behaviour of lecithin surfactants in CFC suspensions: a light scattering study in aerosol propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

The effect of spacers on the delivery of metered dose aerosols of nedocromil sodium and disodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Measuring total and regional lung deposition using inhaled radiotracers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Demonstration of in vivo bioequivalence of a generic albuterol metered-dose inhaler to Ventolin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Inflammation and airway function in asthma: what you see is not necessarily what you get

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900079-6

7 January 2021

10.1016/S0169-409X(03)00079-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842602%20AND%20SRC:MED&resulttype=core&format=json

release_og466zly5ba33l2jrtzpd3s5pm

5 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/og466zly5ba33l2jrtzpd3s5pm

24 November 2022

mapped directly with Wikidata item

1 reference